Purpose. The effect-plasma concentration relationship of etomidate was stud
ied in the rat using electroencephalographic changes as a pharmacodynamic p
arameter.
Methods. Etomidate was infused (50 mg/kg/h) in chronically instrumented rat
s (n = 6) until isoelectric periods of 5 s or longer were observed in the e
lectroencephalogram (EEG). The EEG was continuously recorded during the exp
eriment and frequent arterial blood samples were taken for determination of
etomidate plasma concentrations. The changes observed in the raw EEG signa
l were quantified using aperiodic analysis in the 2.5-7.5 Hz frequency band
. The return of the righting reflex was used as another parameter of anesth
esia.
Results. A mean dose of 8.58 +/- 0.41 mg/kg needed to be infused to reach t
he end point of 5 s isoelectric EEG. The plasma concentration time profiles
were most adequately fitted using a three-exponential model. Systemic clea
rance, volume of distribution at steady-state and elimination half-life ave
raged 93 +/- 6 ml/min/kg, 4.03 +/- 0.24 l/kg and 59.4 +/- 10.7 min respecti
vely. The EEG effect-plasma concentration relationship was biphasic exhibit
ing profound hysteresis. Semi-parametric minimization of this hysteresis re
vealed an equilibration half-life of 2.65 +/- 0.15 min, and the biphasic ef
fect-concentration relationship was characterized nonparametrically by desc
riptors. The effect-site concentration at the return of the righting reflex
was 0.44 +/- 0.03 mu g/ml.
Conclusions. The results of the present study show that the concentration-e
ffect relationship of etomidate can be characterized in individual rats usi
ng aperiodic analysis in the 2.5-7.5 Hz frequency band of the EEG. This cha
racterization can be very useful for studying the influence of diseases on
the pharmacodynamics of etomidate in vivo.